T1	food 0 12	Fruit juices
T2	pharmacokinetics 102 114	availability
T3	parameter 1033 1039	IC(50)
T4	food 1071 1081	grapefruit
T5	food 1083 1089	orange
T6	food 1095 1107	apple juices
T7	dosage 1111 1132	5% of normal strength
T8	interaction 1142 1149	reduced
T9	enzyme 1156 1160	OATP
T10	enzyme 1169 1173	oatp
T11	drug 118 130	fexofenadine
T12	component 1184 1210	6',7'-Dihydroxybergamottin
T13	enzyme 1234 1239	oatp3
T14	enzyme 1244 1249	oatp1
T15	parameter 1251 1257	IC(50)
T16	component 1283 1298	furanocoumarins
T17	interaction 13 20	inhibit
T18	component 1303 1316	bioflavonoids
T19	interaction 1322 1329	reduced
T20	enzyme 1334 1339	oatp3
T21	food 1350 1360	Grapefruit
T22	food 1362 1368	orange
T23	food 1374 1386	apple juices
T24	interaction 1387 1396	decreased
T25	drug 1401 1413	fexofenadine
T26	pharmacokinetics 1414 1460	area under the plasma concentration-time curve
T27	pharmacokinetics 1462 1465	AUC
T28	pharmacokinetics 1472 1483;1489 1502	peak plasma concentration
T29	pharmacokinetics 1504 1510	C(max)
T30	pharmacokinetics 1521 1538	urinary excretion
T31	value 1549 1552	30%
T32	value 1556 1559	40%
T33	food 1574 1579	water
T34	interaction 1581 1595	with no change
T35	pharmacokinetics 1617 1623	C(max)
T36	pharmacokinetics 1625 1646	elimination half-life
T37	pharmacokinetics 1648 1663	renal clearance
T38	pharmacokinetics 1668 1680	urine volume
T39	population 1684 1690	humans
T40	drug 1702 1714	fexofenadine
T41	pharmacokinetics 1715 1718	AUC
T42	food 1724 1729	juice
T43	food 1799 1804	water
T44	food 1819 1831	Fruit juices
T45	component 1836 1848	constituents
T46	interaction 1865 1875	inhibitors
T47	enzyme 1879 1884	OATPs
T48	enzyme 1890 1904	P-glycoprotein
T49	interaction 1927 1933	reduce
T50	mode 1934 1938	oral
T51	drug 1939 1943	drug
T52	pharmacokinetics 1944 1959	bioavailability
T53	food 197 203	fruits
T54	pharmacokinetics 2008 2018	absorption
T55	component 208 226	their constituents
T56	enzyme 230 244	P-glycoprotein
T57	enzyme 249 287	organic anion transporting polypeptide
T58	enzyme 289 293	OATP
T59	population 306 314	in vitro
T60	pharmacokinetics 322 338	drug disposition
T61	population 342 348	humans
T62	enzyme 359 373	P-glycoprotein
T63	drug 383 390	digoxin
T64	drug 394 405	vinblastine
T65	population 431 467	polarized epithelial cell monolayers
T66	enzyme 469 473	OATP
T67	drug 483 495	fexofenadine
T68	mode 548 552	oral
T69	dosage 573 579	120 mg
T70	drug 580 592	fexofenadine
T71	food 611 616	water
T72	dosage 618 630	25%-strength
T73	food 631 647	grapefruit juice
T74	dosage 652 667	normal-strength
T75	food 668 678	grapefruit
T76	food 680 686	orange
T77	food 691 703	apple juices
T78	dosage 705 710	1.2 L
T79	duration 711 723	over 3 hours
T80	studyType 730 762	randomized 5-way crossover study
T81	population 766 785	10 healthy subjects
T82	food 796 812	Grapefruit juice
T83	food 817 825	segments
T84	food 830 841	apple juice
T85	interaction 84 92	decrease
T86	dosage 845 866	5% of normal strength
T87	interaction 867 880	did not alter
T88	enzyme 881 895	P-glycoprotein
T89	food 906 924	Grapefruit extract
T90	interaction 925 932	reduced
T91	mode 97 101	oral
#1	AnnotatorNotes T60	biodisponibilité
A1	valence T34 Négation
A2	valence T24 Diminution
A3	valence T8 Diminution
A4	valence T19 Diminution
A5	valence T49 Diminution
A6	valence T90 Diminution
A7	valence T87 Négation
A8	valence T85 Diminution
R1	transporter_inhibition Arg1:T1 Arg2:T11	
R2	transporter_inhibition Arg1:T21 Arg2:T25	
R3	transporter_inhibition Arg1:T22 Arg2:T25	
R4	transporter_inhibition Arg1:T23 Arg2:T25	
R5	absorption_decrease Arg1:T44 Arg2:T51	
R6	absorption_decrease Arg1:T45 Arg2:T51	
R7	transporter_inhibition Arg1:T44 Arg2:T51	
R8	transporter_inhibition Arg1:T45 Arg2:T51	
R9	transporter_inhibition Arg1:T33 Arg2:T25	
#2	AnnotatorNotes R9	absence
